Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Drug-Related Side Effects and Adverse Reactions 19Head and Neck Neoplasms 15Lung Neoplasms 12Radiation Injuries 11Ovarian Neoplasms 10Leukemia 9Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Ovarian Epithelial 8Carcinoma, Non-Small-Cell Lung 8Leukemia, Myeloid, Acute 7Sarcoma 6Lymphoma, Non-Hodgkin 6Lymphoma 6Hodgkin Disease 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Breast Neoplasms 5Neurotoxicity Syndromes 4Multiple Myeloma 4Xerostomia 3Waldenstrom Macroglobulinemia 3Uterine Cervical Neoplasms 3Testicular Neoplasms 3

Interventions

Acupuncture Therapy 10Exercise 7Cryotherapy 6Paclitaxel 5Glutamine 5Surveys and Questionnaires 3Duloxetine Hydrochloride 3Dexamethasone 3Bortezomib 3Acetylcysteine 3pembrolizumab 2enfortumab vedotin 2Thioctic Acid 2Tablets 2Sodium Chloride 2Saline Solution 2Physical Therapy Modalities 2Low-Level Light Therapy 2Lenalidomide 2Fish Oils 2Fatty Acids, Omega-3 2ziconotide 1sagopilone 1nicotinamide-beta-riboside 1nabilone 1glutamic acid diethyl ester 1eribulin 1allantoicase 1Yoga 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Amifostine × Clear all
NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

GOG Foundation

Phase 3 Completed
100 enrolled
Gynecologic

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡